| 영문 | pancreatic duct | 한글 | 이자관, 췌장관 |
|---|---|---|---|
| 설명 | 이자에서 이자액을 분비하도록 샘창자로 이어진 관. 이자관은 샘창자의 중간부에서 온쓸개관과 같이 개구한다. |
||
| 영문 | oral administration | 한글 | 경구복용 |
|---|---|---|---|
| 설명 | 약을 투여하는 방법에는 여러 가지가 있다. 크게 나누어 보면, 입을 거쳐 위창자계를 통해 넣는 방법과 위창자계를 통하지 않고 바로 혈액으로 넣는 방법이 있다. 위창자계를 통하지 않는 방법으로 가장 흔한 방법은 주사를 이용하는 방법이다. 하지만, 이외에 항문을 통해 넣는 좌약식방법과 혀밑에 넣는 혀밑투여법도 있다. 그러나 대부분의 약제는 경구복용을 하게 된다. 경구복용에 대한 약자는 p.o.(per oral)로 표기한다. 경구복용제의 단점은 복용한 약제가 위창자관계를 거치면서 사람마다 각기 다른 흡수정도와 대사정도를 거치게 되므로 일정한 농도유지가 어렵다는데 있다. 또한 경구복용제의 모양이 캡슐형인지, 혹은 가루형인지에 따라서도 같은 약이지만, 서로 다른 효과를 나타낼 수 있다. |
||
| 영문 | oral cavity | 한글 | 구강 |
|---|---|---|---|
| 설명 | 입을 벌여서 입속에서 볼 수 있는 공간으로 입천장, 편도, 목젖을 볼 수 있다.  |
||
| 영문 | oral cavity | 한글 | 입안 |
|---|---|---|---|
| 설명 | 입을 벌여서 입속에서 볼 수 있는 공간으로 입천장, 편도, 목젖을 볼 수 있다. |
||
| ORS | olfactory reference syndrome; oral rehydration solution; oral surgery, oral surgeon; Orthopaedic Res... |
|---|---|
| HELLP | hemolysis, elevated liver enzymes, and low platelet count [syndrome] |
| BPTI | basic pancreatic trypsin inhibitor; basic polyvalent trypsin inhibitor; bovine pancreatic trypsin in... |
| OCP | octacalcium phosphate; ocular cicatricial pemphigoid; oral case presentation; oral contraceptive pil... |
| OET | oral endotracheal tube; oral esophageal tube |
| CYPs | Cytochrome P450 enzymes |
|---|---|
| HELLP | Haemolysis, Elevated Liver Enzymes and Low Platelets |
| HELLP | Hemolysis, Elevated Liver enzymes, and Low Platelet count |
| SBE | Starch branching enzymes |
| UBCs | Ubiquitin conjugating enzymes |
| complement activating enzymes | <enzyme> Enzymes present in the complement system which activate one or more components in the system. Registry number: EC 3.- (12 Dec 1998) |
|---|---|
| hydrolyzing enzymes | <enzyme> Registry number: EC 3. (12 Dec 1998) |
| splitting enzymes | Enzyme's that, like aldolases, catalyze the conversion of a molecule into two smaller molecules without the addition or subtraction of any atoms. (05 Mar 2000) |
| deamidizing enzymes | <enzyme> Registry number: EC 3.5. (12 Dec 1998) |
| deaminating enzymes | Enzymes catalyzing simple hydrolysis of C-NH2 bonds of purines, pyrimidines, and pterins, usually named in terms of the substrate, e.g., guanine deaminases, adenosine deaminases, AMP deaminases, pterin deaminases and thus producing ammonia; not generally used for deamination of noncyclic amides. Deaminases are distinguished from ammonia-lyases (EC group 4.3.1) in that the latter produce an unsaturation at the point of NH3 removal. Synonym: deaminating enzymes. (05 Mar 2000) |
| debranching enzymes | Enzyme's that bring about destruction of branches in glycogen; formerly considered to be one enzyme, now known to be a mixture of transferases (4-alpha-d-glucanotransferase) and hydrolases (amylo-1,6-glucosidase). Synonym: debranching factors. (05 Mar 2000) |
| digestive enzymes | Enzymes that are utilised in the digestive system, enzymes that are hydrolases of macromolecules (e.g., amylases, proteinases). (05 Mar 2000) |
| DNA restriction enzymes | <enzyme> Enzymes that are part of the restriction-modification systems. They catalyze the endonucleolytic cleavage of DNA sequences which lack the species-specific methylation pattern in the host cell's DNA. Cleavage yields random or specific double-stranded fragments with terminal 5'-phosphates. The function of restriction enzymes is to destroy any foreign DNA that invades the host cell. most have been studied in bacterial systems, but a few have been found in eukaryotic organisms. They are also used as tools for the systematic dissection and mapping of chromosomes, in the determination of base sequences of dnas, and have made it possible to splice and recombine genes from one organism into the genome of another. Registry number: EC 3.1.21 (12 Dec 1998) |
| DNA restriction-modification enzymes | Systems consisting of two enzymes, a modification methylase and a restriction endonuclease. They are closely related in their specificity and protect the DNA of a given bacterial species. The methylase adds methyl groups to adenine or cytosine residues in the same target sequence that constitutes the restriction enzyme binding site. The methylation renders the target site resistant to restriction, thereby protecting DNA against cleavage. (12 Dec 1998) |
| transferring enzymes | <enzyme> Transferases are enzymes transferring a group, for example, the methyl group or a glycosyl group, from one compound (generally regarded as donor) to another compound (generally regarded as acceptor). The classification is based on the scheme "donor:acceptor group transferase". Registry number: EC 2. (12 Dec 1998) |
| enzymes, coenzymes, and enzyme inhibitors | Proteins or RNA that act as biological catalysts, their cofactors, and inhibitors. (12 Dec 1998) |
| enzymes, immobilised | Enzymes which are immobilised on or in a variety of water-soluble or water-insoluble matrices with little or no loss of their catalytic activity. Since they can be reused continuously, immobilised enzymes have found wide application in the industrial, medical and research fields. (12 Dec 1998) |
| accessory pancreatic duct | The excretory duct of the head of the pancreas, one branch of which joins the pancreatic duct, the other opening independently into the duodenum at the lesser duodenal papilla. Synonym: ductus pancreaticus accessorius, Bernard's canal, Bernard's duct, ductus dorsopancreaticus, Santorini's canal, Santorini's duct. (05 Mar 2000) |
| artery of the pancreatic tail | Origin, splenic artery near the left gastroepiploic; distribution, the tail of the pancreas; anastomoses, with other pancreatic arteries. Synonym: arteria caudae pancreatis, caudal pancreatic artery. (05 Mar 2000) |
| cancer, pancreatic | Cancer of the organ which produces many juices that are important for digesting food as well as hormones, such as insulin and glucagon. Pancreatic cancer has been called a silent disease because early pancreatic cancer usually does not cause symptoms. If the tumour blocks the common bile duct and bile cannot pass into the digestive system, the skin and whites of the eyes may become yellow, and the urine darker as a result of accumulated bile pigment called bilirubin. This condition is referred to as jaundice. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|